We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Posiphen® Dose-Finding, Biomarker Study in Early Alzheimer's and Parkinson's Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04524351
Recruitment Status : Completed
First Posted : August 24, 2020
Last Update Posted : May 6, 2022
Information provided by (Responsible Party):
Annovis Bio Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : August 16, 2021
Actual Study Completion Date : January 31, 2022